Episode Details
Back to Episodes
SPECIAL | Why Americans are making homegrown GLP-1s
Published 2 months, 3 weeks ago
Description
High costs. Limited supply. No insurance coverage. All of these are motivating some patients to cook up unregulated “gray GLP-1” drugs at home. Health experts are worried. Why are people willing to risk injecting homemade drugs in an unregulated, non-sterile medical environment and what needs to change before access and safety improve? USA TODAY Wellness Reporter Nicole Fallert joins The Excerpt to share her reporting on this alarming trend.
Have feedback on the show? Please send us an email at podcasts@usatoday.com.
Episode transcript available here.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.